The India telemedicine market size reached US$ 2.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 16.9 Billion by 2032, exhibiting a growth rate (CAGR) of 23.88% during 2024-2032.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2023
|
Forecast Years
|
2024-2032
|
Historical Years
|
2018-2023
|
Market Size in 2023
|
US$ 2.5 Billion |
Market Forecast in 2032
|
US$ 16.9 Billion |
Market Growth Rate 2024-2032 | 23.88% |
Telemedicine, or telehealth, is a practice that enables medical practitioners to provide various clinical and non-clinical services, including consultation, examination, diagnosis, and treatments to patients through digital telecommunications technology. These services can be executed with the utilization of remote patient monitoring (RPM), mobile health (mHealth) applications, and video conferencing. Telemedicine assists in renewing or writing a prescription, delivering health information, and providing appropriate medical attention to the patients at lower costs and enhanced convenience. On account of these properties, it is extensively deployed for teleconsultation, telemonitoring, and medical education and training purposes. At present, it is available in varying mode types, such as web-based, cloud-based, and on-premises delivery.
The increasing prevalence of various chronic and cardiovascular diseases (CVDs), especially amongst the geriatric population has prompted an increase in the need for effective home monitoring systems, wearables, smartwatches, and smartphone applications for checking various health parameters, including blood pressure sugar and sleeping patterns. This, in turn, is primarily driving the India telemedicine market growth. Additionally, the Government of India (GoI) is undertaking numerous initiatives to strengthen the healthcare information (HCIT) sector, such as the provision of telemedicine services to remotely monitor, diagnose, and provide consultation to patients. This is especially helpful during the coronavirus disease (COVID-19) pandemic and the consequent implementation of mandatory lockdowns as outpatient patients are preferring to avail telemedicine services to reduce the spread of the virus. In line with this, the rising awareness amongst patients regarding the several beneficial properties offered by telemedicine, such as virtual assistance, convenience, and no requirement to physically visit hospitals or clinics has, in turn, led to its escalated demand. Additionally, significant technological advancements and the integration of chatbots and robots on online portals and smartphone applications for acquiring personal- and health-related information is acting as another growth-inducing factor. Other factors, such as extensive research and development (R&D) activities and strategic collaborations amongst key players and healthcare professionals for designing advanced medical diagnostic technologies are creating a positive outlook for the market across the country.
IMARC Group provides an analysis of the key trends in each sub-segment of the India telemedicine market report, along with forecasts at the country and regional level from 2024-2032. Our report has categorized the market based on component, type, deployment mode, modality, application and end user.
Breakup by Component:
Breakup by Type:
Breakup by Deployment Mode:
Breakup by Modality:
Breakup by Application:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Report Features | Details |
---|---|
Base Year of the Analysis | 2023 |
Historical Period | 2018-2023 |
Forecast Period | 2024-2032 |
Units | US$ Billion |
Segment Coverage | Component, Type, Deployment Mode, Modality, Application, End User, Region |
Region Covered | North India, West and Central India, South India, East India |
Customization Scope | 10% Free Customization |
Report Price and Purchase Option | Single User License: US$ 2699 Five User License: US$ 3699 Corporate License: US$ 4699 |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
We expect the India telemedicine market to exhibit a CAGR of 23.88% during 2024-2032.
The improving healthcare information (HCIT) sector, along with rising integration of AI-based chatbots with online portals and smartphone applications to acquire personal and health-related information of individuals, is currently driving the India telemedicine market.
The sudden outbreak of the COVID-19 pandemic has led to the growing adoption of telemedicine services to remotely monitor, diagnose, and provide consultation to the patients infected with the coronavirus disease and to combat the further spread of the COVID-19 infection.
Based on the component, the India telemedicine market has been bifurcated into software and services and hardware, where hardware component represents the largest market share.
Based on the type, the India telemedicine market can be segregated into tele-hospitals, mHealth, and tele-homes. Currently, tele-hospitals account for the majority of the total market share.
Based on the deployment mode, the India telemedicine market has been divided into on-premises, cloud-based, and web-based. Among these, cloud-based exhibits a clear dominance in the market.
Based on the modality, the India telemedicine market can be categorized into store and forward, real time, and others. Currently, real time modality holds the majority of the total market share.
Based on the application, the India telemedicine market has been segmented into teleradiology, telepsychiatry, telepathology, teledermatology, telecardiology, and others. Among these, teleradiology represents the largest market share.
Based on the end user, the India telemedicine market can be bifurcated into providers, payers, patients, and others. Currently, providers account for the majority of the total market share.
On a regional level, the market has been classified into North India, West and Central India, South India, and East India, where South India currently dominates the market.